Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes
- 26 April 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 3 (3) , 355-369
- https://doi.org/10.1517/17425247.3.3.355
Abstract
(2006). Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opinion on Drug Delivery: Vol. 3, No. 3, pp. 355-369. doi: 10.1517/17425247.3.3.355Keywords
This publication has 81 references indexed in Scilit:
- Inhibition of Metastatic Tumor Growth in Mouse Lung by Repeated Administration of Polyethylene Glycol-Conjugated CatalaseClinical Cancer Research, 2004
- Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cellsExperimental Cell Research, 2004
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- Polysialic acids: potential in drug deliveryPublished by Wiley ,2001
- Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancyBreast Cancer Research and Treatment, 1996
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growthClinical & Experimental Metastasis, 1994
- Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapyin vivoClinical & Experimental Metastasis, 1994
- The Cellular Basis of Site-Specific Tumor MetastasisNew England Journal of Medicine, 1990
- Hepatic uptake of proteins coupled to fetuin glycopeptideBiochemical and Biophysical Research Communications, 1971